EbookBell.com

Most ebook files are in PDF format, so you can easily read them using various software such as Foxit Reader or directly on the Google Chrome browser.
Some ebook files are released by publishers in other formats such as .awz, .mobi, .epub, .fb2, etc. You may need to install specific software to read these formats on mobile/PC, such as Calibre.

Please read the tutorial at this link: https://ebookbell.com/faq

We offer FREE conversion to the popular formats you request; however, this may take some time. Therefore, right after payment, please email us, and we will try to provide the service as quickly as possible.

For some exceptional file formats or broken links (if any), please refrain from opening any disputes. Instead, email us first, and we will try to assist within a maximum of 6 hours.

EbookBell Team

Drugsfrom Discovery To Approval 1st Edition Rick Ng

Name: Drugsfrom Discovery To Approval 1st Edition Rick Ng
SKU: BELL-1126094
Price: 31.00 USD
Availability: InStock
Rating: 4.7 (56 reviews)

SKU: BELL-1126094

$ 31.00 ~~$ 45.00~~ (-31%)

4.7

56 reviews

Drugsfrom Discovery To Approval 1st Edition Rick Ng instant download after payment.

Publisher: Wiley-Liss

File Extension: PDF

File size: 16.8 MB

Pages: 368

Author: Rick Ng

ISBN: 9780471601500, 0471601500

Language: English

Year: 2004

Edition: 1

Product desciption

Drugsfrom Discovery To Approval 1st Edition Rick Ng by Rick Ng 9780471601500, 0471601500 instant download after payment.

SynopsisA comprehensive guide to the complex and lengthy process by which a drug arrives on the market. The process has elements of scientific research, medical ethics, business, and regulation; statistics show that out of 5,000 compounds with initial promise, five will go into human clinical trials and one will become an approved drug. The reference lists current FDA and European guidelines and covers regulatory authorities and processes in Japan and China. Of interest to professionals in the pharmaceutical industry as well as students of pharmacy, medicine, or life sciences and others interested in drug discovery. Ng is manager of regulatory affairs for the Biopharmaceutical Manufacturing Technology Centre, Singapore.